Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deng Zhan Sheng Mai Capsules in Vascular Cognitive Impairment
ChiCTR-IPR-16009289Phase 4Recruiting
- Sponsor
- Centre for Beijing Aging Brain Rejuvenation initiative.Beijing Normal University
- Start
- Sep 2016
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in vascular cognitive disorder (VCD) and vascular dementia comparing Dengzhan Shengmai Jiaonang with Placebo (2 arms). Primary endpoints: ADAS-cog, Mini-Mental State Examination (MMSE) and 10 more. Started Sep 2016; status: recruiting.
02
Drugs
Dengzhan Shengmai
03
Conditions
vascular cognitive disorder (VCD)vascular dementia
Beyond the preview
Go deeper on ChiCTR-IPR-16009289.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-16009289.